Navigation Links
Life Support Technologies Group Announces That Hyperbaric Medicine Shown to Benefit Breast Cancer Survivors Undergoing Breast Reconstruction
Date:11/26/2013

Tarrytown, NY (PRWEB) November 26, 2013

The clinical benefits of using hyperbaric oxygen therapy for breast cancer patients undergoing breast reconstruction has been described in a poster presentation at the 28th Annual Clinical Symposium on Advances in Skin & Wound Care held on October 23-27 at Lake Buena Vista, FL. In threatened mastectomy skin flaps treated at Good Samaritan Hospital, Suffern, NY, over a 4 year, 15 patient period, an 87.5% success rate was realized when hyperbaric oxygen therapy was used, against a success rate of only 14.2% in cases where it was not used.

Laura Sudarsky, MD, FACS, the study’s Principal Investigator, said, “Complications from mastectomy and breast reconstruction can be devastating to our patients and may delay their cancer treatment, resulting in longer hospitalizations. This study indicates that hyperbaric treatment helps reduce some complications so the patients can resume their lives and cancer treatment with less delay.”

Authors of the poster presentation, titled, “Hyperbaric Oxygen as an Adjunctive Therapy for Threatened Post Mastectomy Skin Flaps in the Setting of Staged Prosthetic Breast Reconstruction,” are: Donovan Rosas, MD; Laura Sudarsky, MD, FACS; Michele Gilbert MSN, NP-C; all of Good Samaritan Regional Medical Center, Suffern, NY; and, Glenn J. Butler, CEO of the Life Support Technologies group (LST), Tarrytown, NY.

Hyperbaric treatment involves placing a patient in a specially constructed chamber under increased atmospheric pressure and administering 100% oxygen for the patient to breathe. From a medical standpoint, this treatment does several things: it highly oxygenates tissue to help restore viability, it promotes the building of capillary beds, kills bacteria, makes several facets of the immune system more effective, and helps wounds heal faster.

According to the National Breast Cancer Foundation, Inc., 1 out of 8 women will be diagnosed with breast cancer during their lifetimes. The National Cancer Institute at the National Institutes of Health estimates that 2,829,041 women are currently living with breast cancer in the United States.

The presentation had several important conclusions based on the successful, early use of hyperbaric medicine for salvage of the reconstructed breast that presented a threatened mastectomy skin flap. Necrosis represents one of the most significant threats to successful breast reconstruction; in such cases, early identification and initiation of hyperbaric therapy (HBOT) is critical. The average time for initial HBOT was 8.57 days, whereas the lone HBOT failure has been attributed to significant HBOT treatment delay. Aggressive surgical debridement must also be used early in the treatment cycle and coupled with HBOT to salvage breast reconstructions and improve patient outcomes.

Glenn Butler, CEO of the Life Support Technologies group, which provides hyperbaric medicine services to Good Samaritan Regional Medical Center and 8 other hospitals, said, “This study shows how great an impact the proper use of hyperbaric treatment has when coordinated with other medical disciplines. The results are better outcomes for patients, reduced suffering, and savings in medical costs. Based on these results, a larger study is warranted.”

For more information see:

Clinical Symposium on Advances in Skin & Wound Care
http://lwwconferences.com/event.aspx?eid=6

Hyperbaric Oxygen as an Adjunctive Therapy for Threatened Post Mastectomy Skin Flaps in the Setting of Staged Prosthetic Breast Reconstruction
http://www.lifesupport-usa.com/

Good Samaritan Regional Medical Center
http://bschs.bonsecours.com/find-a-facility-good-samaritan-regional-medical-center.html

Undersea & Hyperbaric Medical Society (UHMS)
http://membership.uhms.org/

The National Breast Cancer Foundation, Inc.
http://www.nationalbreastcancer.org/

National Cancer Institute
http://www.cancer.gov/

About the Life Support Technologies Group (LST)

Life Support Technologies Group (LST) is a Tarrytown, NY-based medical and life-support engineering company that was founded 20 years ago by Glenn Butler, CEO. LST specializes in Advanced Wound Care and Hyperbaric Medicine and currently provides services to 9 hospitals in the greater NY-region.

Glenn Butler, CEO
Life Support Technologies Group

(914) 333-8412
http://www.lifesupport-USA.com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11355396.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Supporting LGB children may influence their long-term health, BU study finds
2. International breast health global summit will focus on supportive care and quality of life
3. Americans Support Medicare Reform, But Not on Their Dime: Poll
4. Decision support system translates into high percentage of positive chest CT examinations
5. More cutting-edge cancer research supported by industry
6. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
7. Behavioral support from peers, staff lowers patients blood pressure
8. Study supports urate protection against Parkinsons disease, hints at novel mechanism
9. The W3 Project Receives Support from Doulton for Emergency Relief Efforts
10. Dietary fiber alters gut bacteria, supports gastrointestinal health
11. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... 2017 , ... Kevin Harrington (one of the original Sharks from mega-hit reality ... the topic of Beauty and Personal Care. , Everyone makes New ... to commit to these changes than beginning with personal care and beauty products? AsSeenOnTV.pro ...
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting ... Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted ... providers. , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug ...
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, pocket knife, luggage ... Cradle to Cradle Product Design Challenge , the Cradle to Cradle Products Innovation ... circular design challenges scheduled to run through early 2018. The challenges are presented by ...
(Date:1/17/2017)... ... ... SC&H Group, a leading audit, tax, and consulting firm, announced that Chris ... practice . Rossi is the third technology consulting leader to join SC&H Group’s IT ... the practice continues to expand.     , Bringing more than 25 years of business consulting ...
(Date:1/17/2017)... ... January 17, 2017 , ... The Sharie Withers Agency, a ... the latest beneficiary of their thriving community involvement program. The current campaign fundraises ... the dreams of terminally ill patients. Donations to this worthy cause may now ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017 North America ... GlobalData,s new report, "North America Insulin Delivery Market Outlook ... America Insulin Delivery market. The report provides value, in ... prices (USD) within market segments - Insulin Pens, Insulin ... The report also provides company shares and distribution shares ...
(Date:1/17/2017)... 2017 Research and Markets has announced ... - 2024" report to their offering. ... This new report revisits the market ... was issued in May of 2015. Self-healing is an area of ... analysis we projected a market potential of $2.7 billion ($US) by ...
(Date:1/17/2017)... Israel , January 17, 2017 Management ... TyrNovo, Ltd.   KIT-302 Development On Track For ... FDA in Q1 2017   ... Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV ; ... update call on Monday, January 23 rd at 8:30am Eastern Time to ...
Breaking Medicine Technology: